FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...
Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...
AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...
Inclusive leadership is demonstrated through consistent respect, psychological safety, and communication that makes patients ...
Oncology physical therapist Dr. Leslie Waltke demonstrates calf raises, a simple at-home exercise to help rebuild lower body ...
Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.
Initial remission underscored a persistent survivorship burden, characterized by mistrust of the body and concurrent gratitude, fear, and anxiety despite family-wide relief. Recurrence catalyzed ...
Catina Pitzen, BSN, RN, of Eisai US, leads Columbus P.ink Day, helping breast cancer survivors transform surgical scars into meaningful tattoo art.
Elizabeth Dennis describes the testing process following a new lung cancer diagnosis. Initial tissue biopsy is sent for next-generation sequencing (NGS), although repeat tissue sampling or liquid ...
Her proposal to quantify ropeginterferon alfa-2b transport during pregnancy catalyzed cross-disciplinary collaboration and ...
A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...
Catina Pitzen, BSN, RN, of Eisai US, leads Columbus P.ink Day, helping breast cancer survivors transform surgical scars into meaningful tattoo art.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results